William A. Wexler

Insider Reports History

Entity
Individual
Location
12 Gill Street, Suite 4650, Woburn, MA
Signature
/s/ Ryan M. Rourke Reed, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by William A. Wexler:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Comera Life Sciences Holdings, Inc. Director Common Stock 20.8K $1.47K $0.07 Nov 15, 2023 Direct
Brooklyn ImmunoTherapeutics, Inc. Director Stock Option (right to buy) 166K Aug 1, 2022 Direct
Comera Life Sciences Holdings, Inc. Director Stock Option (Right to Purchase) 75.4K Nov 9, 2023 Direct

Insider Reports Filed by William A. Wexler

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CMRA Comera Life Sciences Holdings, Inc. Nov 15, 2023 1 $0 4 Nov 17, 2023 Director
CMRA Comera Life Sciences Holdings, Inc. Nov 9, 2023 1 $0 4 Nov 14, 2023 Director
CMRA Comera Life Sciences Holdings, Inc. Aug 31, 2023 1 $0 4 Sep 1, 2023 Director
CMRA Comera Life Sciences Holdings, Inc. Aug 11, 2023 1 $0 4 Aug 15, 2023 Director
CMRA Comera Life Sciences Holdings, Inc. May 12, 2023 1 $0 4 May 16, 2023 Director
CMRA Comera Life Sciences Holdings, Inc. Feb 14, 2023 1 $0 4 Feb 16, 2023 Director
CMRA Comera Life Sciences Holdings, Inc. Aug 9, 2022 1 $0 4 Aug 11, 2022 Director
ERNA Brooklyn ImmunoTherapeutics, Inc. Aug 1, 2022 2 $0 4 Aug 3, 2022 Director
ERNA Brooklyn ImmunoTherapeutics, Inc. Jun 5, 2022 0 $0 3 Jun 7, 2022 Director
CMRA Comera Life Sciences Holdings, Inc. May 19, 2022 0 $0 3 May 20, 2022 Director